Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

EMA and WHO mark ten years of collaboration to advance global access to medicines

EMA and the World Health Organization (WHO) are celebrating a decade of formal collaboration and shared commitment to address global health challenges. Since the signing of a confidentiality arrangement in September 2015, their partnership has focused on cooperation on scientific evaluation, capacity building, enhancing regulatory efficiency to contribute to public health worldwide.

A key initiative for collaboration is EMA’s EU Medicines for all (EU-M4all) programme that enables EMA, in cooperation with the WHO, to support global regulatory capacity building and contribute to the protection and promotion of public health beyond the EU. The latest example of this successful initiative is a recommendation issued by EMA in July 2025 for Yeytuo (lenacapavir), a new medicine for pre-exposure prophylaxis (PrEP) against sexually acquired human immunodeficiency virus type 1 (HIV-1) in adults and adolescents at high risk of becoming infected. In addition to WHO, experts from Uganda, Zambia, Kenya, Nigeria, Zimbabwe, South Africa, Thailand and Vietnam participated in the evaluation. This inclusive approach supports regulatory harmonisation and strengthens global capacity to protect public health.

More information on the EMA Website.


OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (22 novembre 2025). EMA and WHO mark ten years of collaboration to advance global access to medicines. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/156rk


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.